Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)

被引:7
作者
Jia, XiaoXiao [1 ,2 ]
Shi, Ming [3 ]
Wang, Qifei [1 ,2 ]
Hui, Jessica [4 ]
Shofaro, Joshua Hui [1 ,2 ]
Erkhembayar, Ryenchindorj [5 ]
Hui, Mizhou [1 ,2 ]
Gao, Chenzhe [1 ]
Gantumur, Munkh-Amgalan [1 ]
机构
[1] Northeast Agr Univ, Coll Life Sci, Harbin, Peoples R China
[2] Qingdao Agr Univ, Coll Vet Med, Qingdao, Peoples R China
[3] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China
[4] Stanford Univ, Stanford Canc Inst, Ctr Canc Cell Therapy, Sch Med, Stanford, CA USA
[5] Mongolian Natl Univ Med Sci, Grad Sch, Dept Int Cyber Educ, Ulaanbaatar, Mongolia
关键词
hyaluronic acid; 35kDa hyaluronic acid fragment; B-HA; HA35; molecular weight; inflammation; inflammatory cells; reactive oxygen species; injection safety; MOLECULAR-MASS; 2; DEFICIENCY; EXPRESSION; PAIN; NEUTROPHIL; MICROGLIA; SIGLEC-9; PH-20; HAS2;
D O I
10.2147/JIR.S393495
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Hyaluronic acid (HA) and HA fragments interact with a variety of human body receptors and are involved in the regulation of various physiological functions and leukocyte trafficking in the body. Accordingly, the development of an injectable HA fragment with good tissue permeability, the identification of its indications, and molecular mechanisms are of great significance for its clinical application. The previous studies showed that the clinical effects of injectable 35kDa B-HA result from B-HA binding to multiple receptors in different cells, tissues, and organs. This study lays the foundation for further studies on the comprehensive clinical effects of injectable B-HA. Methods: We elaborated on the production process, bioactivity assay, efficacy analyses, and safety evaluation of an injectable novel HA fragment with an average molecular weight of 35 kDa (35 kDa B-HA), produced by recombinant human hyaluronidase PH20 digestion. Results: The results showed that 35 kDa B-HA induced human erythrocyte aggregation (rouleaux formation) and accelerated erythrocyte sedimentation rates through the CD44 receptor. B-HA application and injection treatment significantly promoted the removal of mononuclear cells from the site of inflammation and into the lymphatic circulation. At a low concentration, 35 kDa B-HA inhibited production of reactive oxygen species and tumor necrosis factor by neutrophils; at a higher concentration, 35 kDa B-HA promoted the migration of monocytes. Furthermore, 35 kDa B-HA significantly inhibited the migration of neutrophils with or without lipopolysaccharide treatment, suggesting that in local tissues, higher concentrations of 35 kDa B-HA have antiinflammatory effects. After 99mTc radiolabeled 35 kDa B-HA was intravenously injected into mice, it quickly entered into the spleen, liver, lungs, kidneys and other organs through the blood circulation. Conclusion: This study demonstrated that the HA fragment B-HA has good tissue permeability and antiinflammatory effects, laying a theoretical foundation for further clinical studies.
引用
收藏
页码:209 / 224
页数:16
相关论文
共 70 条
  • [1] High molecular weight hyaluronan reduces lipopolysaccharide mediated microglial activation
    Austin, James W.
    Gilchrist, Chris
    Fehlings, Michael G.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2012, 122 (02) : 344 - 355
  • [2] Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis
    Bahrami, S. B.
    Tolg, C.
    Peart, T.
    Symonette, C.
    Veiseh, M.
    Umoh, J. U.
    Holdsworth, D. W.
    McCarthy, J. B.
    Luyt, L. G.
    Bissell, M. J.
    Yazdani, A.
    Turley, E. A.
    [J]. INTEGRATIVE BIOLOGY, 2017, 9 (03) : 223 - 237
  • [3] Expression of PH-20 in normal and neoplastic breast tissue
    Beech, DJ
    Madan, AK
    Deng, N
    [J]. JOURNAL OF SURGICAL RESEARCH, 2002, 103 (02) : 203 - 207
  • [4] Hyaluronan: A modulator of the tumor microenvironment
    Chanmee, Theerawut
    Ontong, Pawared
    Itano, Naoki
    [J]. CANCER LETTERS, 2016, 375 (01) : 20 - 30
  • [5] Microglia in Pain: Detrimental and Protective Roles in Pathogenesis and Resolution of Pain
    Chen, Gang
    Zhang, Yu-Qiu
    Qadri, Yawar J.
    Serhan, Charles N.
    Ji, Ru-Rong
    [J]. NEURON, 2018, 100 (06) : 1292 - 1311
  • [6] Hyaluronidase 2 Deficiency Causes Increased Mesenchymal Cells, Congenital Heart Defects, and Heart Failure
    Chowdhury, Biswajit
    Xiang, Bo
    Liu, Michelle
    Hemming, Richard
    Dolinsky, Vernon W.
    Triggs-Raine, Barbara
    [J]. CIRCULATION-CARDIOVASCULAR GENETICS, 2017, 10 (01)
  • [7] Hyaluronidase 2 deficiency is amolecular cause of cor triatriatumsinister in mice
    Chowdhury, Biswajit
    Xiang, Bo
    Muggenthaler, Martina
    Dolinsky, Vernon W.
    Triggs-Raine, Barbara
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 : 281 - 283
  • [8] Murine Hyaluronidase 2 Deficiency Results in Extracellular Hyaluronan Accumulation and Severe Cardiopulmonary Dysfunction
    Chowdhury, Biswajit
    Hemming, Richard
    Hombach-Klonisch, Sabine
    Flamion, Bruno
    Triggs-Raine, Barbara
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (01) : 520 - 528
  • [9] The content and size of hyaluronan in biological fluids and tissues
    Cowman, Mary K.
    Lee, Hong-Gee
    Schwertfeger, Kathryn L.
    McCarthy, James B.
    Turley, Eva A.
    [J]. FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [10] UPTAKE AND DEGRADATION OF HYALURONAN IN LYMPHATIC TISSUE
    FRASER, JRE
    KIMPTON, WG
    LAURENT, TC
    CAHILL, RNP
    VAKAKIS, N
    [J]. BIOCHEMICAL JOURNAL, 1988, 256 (01) : 153 - 158